Abstract:Background An in situ, gelling, dual drug co-delivery system (PEG-PCL-PEG/DDP + MPEG-PCL/PTX [PDMP]) was prepared through the combination of a cisplatin-containing thermosensitive hydrogel (PEG-PCL-PEG/DDP, PECE/DDP) and paclitaxel-loaded polymeric micelles (MPEG-PCL/PTX micelles). Methods PDMP was a free-flowing solution at ambient temperature and formed a non-flowing gel at body temperature, serving as a drug depot for the in situ treatment of lung cancer. The MPEG-PCL/PTX spherical micelles had a diameter of 20.1 nm and a narrow particle size distribution. Paclitaxel loading and encapsulation efficiency of micelles were 3.96 ± 0.03% and 99.18 ± 0.65%, respectively. Findings Compared with blank micelles, paclitaxel-loaded micelles showed significant tumour inhibition in A549 cells. A xenografted lung cancer model was used to evaluate the antitumour efficiency of PDMP in vivo. PDMP was effective in inhibiting tumour growth and prolonging survival time of tumour-bearing BALB/c nude mice. Immunohistochemical images also showed that tumours in the PDMP group had fewer microvessels and lower proliferation activity compared with the control group. Interpretation Prepared PDMP could have potential for in situ local treatment of lung cancer through in vitro minimal invasive injection. An in situ, gelling, dual drug co-delivery system (PEG-PCL-PEG/DDP + MPEG-PCL/PTX [PDMP]) was prepared through the combination of a cisplatin-containing thermosensitive hydrogel (PEG-PCL-PEG/DDP, PECE/DDP) and paclitaxel-loaded polymeric micelles (MPEG-PCL/PTX micelles). PDMP was a free-flowing solution at ambient temperature and formed a non-flowing gel at body temperature, serving as a drug depot for the in situ treatment of lung cancer. The MPEG-PCL/PTX spherical micelles had a diameter of 20.1 nm and a narrow particle size distribution. Paclitaxel loading and encapsulation efficiency of micelles were 3.96 ± 0.03% and 99.18 ± 0.65%, respectively. Compared with blank micelles, paclitaxel-loaded micelles showed significant tumour inhibition in A549 cells. A xenografted lung cancer model was used to evaluate the antitumour efficiency of PDMP in vivo. PDMP was effective in inhibiting tumour growth and prolonging survival time of tumour-bearing BALB/c nude mice. Immunohistochemical images also showed that tumours in the PDMP group had fewer microvessels and lower proliferation activity compared with the control group. Prepared PDMP could have potential for in situ local treatment of lung cancer through in vitro minimal invasive injection.

Paclitaxel-eluting silicone airway stent for preventing granulation tissue growth and lung cancer relapse in central airway pathologies

Rational design of drug-eluting stents via electrospray and in vivo evaluation of preventing oesophageal stricture

Paclitaxel Drug-eluting Tracheal Stent Could Reduce Granulation Tissue Formation in a Canine Model

A Self-Expandable C-shaped 3D Printing Tracheal Stent for Combinatorial Controlled Paclitaxel Release and Tracheal Support

The Anti-Tumor Effects of Lung Cancer-Targeting Long-Circulating Paclitaxel-Containing Liposomes

Investigation of Migration-Preventing Tracheal Stent with High Dose of 5-Fluorouracil or Paclitaxel for Local Drug Delivery.

All-in-one Properties of an Anticancer-Covered Airway Stent for the Prevention of Malignant Central Airway Obstruction.

Lesion-Adaptative Bionic Tracheal Stent with Local Paclitaxel Release for Enhanced Therapy of Tracheal Tumor and Stenosis

Microinjection Molded Biopolymeric Airway Stent with Antibacterial and Anti-Hyperplastic Properties

Endoscopic Airway Stenting for Tracheobronchial Stenosis and Tracheoesophageal Fistula

In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.

Impact of Silicone Stent Placement in Symptomatic Airway Obstruction due to Non-Small Cell Lung Cancer – A French Multicenter Randomized Controlled Study: The SPOC Trial

P204 A paclitaxel–cisplatin loaded thermosensitive hydrogel for in situ treatment of lung cancer

Dual-Functional Esophageal Stent Coating Composed of Paclitaxel-Loaded Electrospun Membrane and Protective Film.

Selection and fabrication of a non-woven polycarbonate urethane cover for a tissue engineered airway stent

Custom silicone Y-stents for the management of anastomotic stenosis in lung transplant recipients

Patterned Drug-Eluting Coatings for Tracheal Stents Based on PLA, PLGA, and PCL for the Granulation Formation Reduction: In Vivo Studies

pH-Responsive Nanoparticles for Delivery of Paclitaxel to the Injury Site for Inhibiting Vascular Restenosis

Clinical assessment of airway stent placement in patients with malignant airway lesions.

Interest of a New Biodegradable Stent Coated with Paclitaxel on Anastomotic Wound Healing after Biliary Reconstruction.

Preparation,in vitro and in vivo evaluation of actively lung targetable microspheres for paclitaxel delivery